行情

AMRN

AMRN

阿玛琳
NASDAQ

实时行情|Nasdaq Last Sale

5.26
+0.28
+5.61%
交易中 11:25 04/02 EDT
开盘
5.30
昨收
4.980
最高
5.75
最低
5.08
成交量
3,528.18万
成交额
--
52周最高
26.12
52周最低
3.950
市值
20.52亿
市盈率(TTM)
-75.1371
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AMRN价格均价为17.36,最高价位51.00,最低价为4.000。

EPS

AMRN 新闻

更多
  • Is Amarin (AMRN) Stock a Solid Choice Right Now?
  • Zacks · 30分钟前
  • Cowen bullish on Amarin, sees potential $20 a share
  • Seeking Alpha - Article · 2小时前
  • Cowen On Amarin Says Thinks A Sale Or CVR 'Makes Sense'
  • Benzinga · 3小时前
  • Amarin: The Possible Procedural Error In The District Court Judgment
  • Seeking Alpha - Article · 5小时前

所属板块

生物技术和医学研究
+1.90%
制药与医学研究
+1.22%

热门股票

代码
价格
涨跌幅

AMRN 简况

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
展开

微牛提供Amarin Corporation plc (ADR)(NASDAQ-AMRN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AMRN股票新闻,以帮助您做出投资决策。